Nurix Therapeutics, Inc. (NRIX) vs Pharvaris N.V. (PHVS)
Nurix Therapeutics, Inc. and Pharvaris N.V. are both Biotechnology companies. Nurix Therapeutics, Inc. and Pharvaris N.V. are of similar size ($2.5B and $2.3B). Pharvaris N.V. has the higher net margin (0.00% vs −928.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Pharvaris N.V. leads on 9 and Nurix Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | NRIX | PHVS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (982.37%) | 0.00% | 0.00% |
| Net margin | (928.44%) | 0.00% | 0.00% |
| Free cash flow margin | (828.28%) | 0.00% | 0.00% |
| Return on equity | (80.30%) | (71.50%) | (57.72%) |
| Return on assets | (60.57%) | (64.43%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack